VICB

The 2023 annual Vanderbilt Institute of Chemical Biology Symposium, featuring prominent scientists—including keynote speaker Dr. John Yates III—will be Aug. 8 at the Student Life Center. Sponsored by Ancora Innovation, the event will include discussions on innovative life science research and drug development, promising a day of knowledge sharing and networking for Vanderbilt students, staff and faculty. Read More

Derek Pratt of the University of Ottawa will present “Endogenous and Exogenous Suppressors of Lipid Peroxidation and Associated Oxidative Cell Death” on Wednesday, March 23, from 12:15 to 1:15 p.m. in MRB III, Room 1220, and on Zoom. Read More

The Vanderbilt Institute of Chemical Biology presents a BioVU panel discussion featuring Vanderbilt University Medical Center researchers Cheryl Gatto, Celeste Jones Paris, Robert Lavieri, Jillian Rhoads and Michael Orr. “Bedside to Bench to Bedside: BioVU Resources in Discovery and Translational Research” will be on Wednesday, Jan. 26, from 12:15 to 1:15 p.m. via Zoom. Read More

The Vanderbilt Institute of Chemical Biology presents Dr. Jim Shayman of the University of Michigan on Wednesday, Jan. 19. Shayman will discuss “The Design and Development of Substrate Reduction Inhibitors for Lysosomal Storage Disorders” beginning at 12:15 p.m. CT. Read More

The Vanderbilt Institute of Chemical Biology’s 500th seminar speaker will be award-winning biochemist, inventor and educator Michael Marletta. His talk will take place on Wednesday, March 24, at 12:15 p.m. CT, when he will discuss the vitality and toxicity of nitric oxide in the body. Read More

Vanderbilt's Center for Technology Transfer and Commercialization, the Vanderbilt Institute of Chemical Biology and Deerfield will bring together experts in discovery and development of antibody therapeutics Jan. 23 to discuss and review state-of-the-art developments in the field. Read More

The Vanderbilt Institute of Chemical Biology (VICB) will hold a Founders’ Celebration mini-symposium on March 28 to acknowledge the contributions of its founders, Lawrence Marnett, PhD, and Ned Porter, PhD, and to celebrate 15-plus years of success as a trans-institutional scientific incubator. Read More

H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB). Read More

Choosing a career is like grading a diamond; you must consider your shortcomings, desires and values as well as your strengths, a biopharmaceutical company executive advised graduate students recently during a recent career conference at Vanderbilt University. Read More

The Vanderbilt DRTC facilitates the discovery, application and translation of scientific knowledge to improve the care of patients with diabetes. The Vanderbilt Diabetes Research and Training Center  announces a new pilot and feasibility program (P&F) for innovative studies that use the VICB High-Throughput Screening Facility,… Read More

Structural biology studies of a bacterial protein suggest a new target for treating life-threatening heart infection. Read More

Vanderbilt researchers have identified small molecules that can restore normal protein expression in human colorectal carcinoma cells and prevent invasive cancer growth. Read More